Mydecine: Psilocybin Sciences

Today we have the pleasure of speaking with Josh Bartch, the CEO of Mydecine, a research & development company with a special interest in psilocybin and psychoactive treatments. We discuss the origins of their work, their team, and current research and practices in the field. Topics covered: Mydecine's mission and commitment to human benefit via fungal discoveryPsilocybin treatment for PTSD and other mental health concernsMachine-learning based drug discoveryFormulation and commercializat...